Safety and efficacy of tirzepatide in transplant recipients: a systematic review and meta-analysis - PubMed
8 hours ago
- #meta-analysis
- #transplant recipients
- #tirzepatide
- Tirzepatide shows potential benefits in solid organ transplant recipients, with an average reduction in hemoglobin A1c of -1.4% and body mass index of -1.2 kg/m².
- Safety analysis indicates a low discontinuation rate of 3.1% due to adverse drug reactions, suggesting good tolerability in this population.
- The review highlights the lack of randomized controlled trials, relying on four observational studies, and calls for larger prospective studies to confirm findings.